Although a proportion of these variants could be de novo, overall they were found in genes more recently understood to cause cancer with less clinical information available and lower penetrance such as DICER1. This was further indicated by the presence of fewer ACMG SF v2.0 cancer variants in comparison to the increased FH risk cohort. The gene discussed is DICER1; the disease is cancer.